Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Trading Down 10.0 % NASDAQ GLMD opened at $2.26 on Thursday. The firm has a market capitalization of […]
Equities research analysts at StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Trading Down 10.0 % NASDAQ GLMD opened at $2.26 on Thursday. The firm has a market capitalization of […]
